PPARβ/δ deficiency in colon cancer cells reduces hypoxia-induced VEGF and IL6 expression, which links PPARβ/δ to tumor angiogenesis and immune response in colon cancer [406]. Here, IL6 is linked to malignant colon neoplasm.